英文摘要 |
The National Health Insurance (NHI) of Taiwan was set up in March 1995, covering about 99.64% of the country's population (23.08 million people) by the end of 2010. Most of the medical institutions (92.1%) have contracts with the Bureau of NHI, Taiwan. The National Health Insurance Research Database (NHIRD) with scrambled-identification numbers of subjects was released by the Bureau of NHI, Taiwan, for academic research. This review study aimed to analyze the research articles published in the international journals using the data from the NHIRD, for example: patients with diabetes mellitus treated with insulin may increase the risk of cancer, but may reduce the risk of cancer after adding metformin; diabetic patients treated with thiazolidinediones may reduce the risk of liver cancer, lung cancer and colorectal cancer, and treated with alpha-glucosidase inhibitors may reduce the risk of lung cancer; statin use may reduce the risk of hepatocellular carcinoma in HBV-infected patients; angiotensin II receptor blockers use may reduce the risk of cancer in patients with hypertension; Angiotensin-converting enzyme inhibitors combined with aspirin or NSAIDs use may reduce the risk of breast cancer in female patients; effective reduction of gastric cancer risk was found in Helicobacter pylori-infected patients with regular use of NSAIDs; patients with benign prostate hypertrophy treated with finasteride may increase the risk of prostate cancer, and treated with dutasteride increased the risk of renal cell cancer. Due to the excessive number of articles, this paper focused on the 28 cancer-related English articles published within 5 years. The research topics from the selected articles included the issues about whether the medications of certain chronic diseases (e.g., diabetes mellitus) reduces or increases the risk of cancer. These findings suggested that patients with higher risks of cancers due to some medications for chronic conditions need more attentions from physicians. Physicians should also communicate with patients and their families about the related health risks. |